At the same time, gross spending increased ninefold, from about $1 billion in 2019 to almost $9 billion in 2024, and gross spending per GLP-1 prescription reached $1,000 in 2024
Although promising, most of the published studies have been in animal models rather than large-scale human clinical trials
The combination of excitotoxicity and mitochondrial dysfunction accelerates neuronal death
Third, marketplace "bacteriostatic water" listings have been documented (per the cloudy peptide reference) to actually be mislabeled saline a product that looks like bac water on the label but lacks benzyl alcohol entirely
Speak With LumaLex Law If you are a physician, compounding pharmacy, clinic operator, or peptide-adjacent business, now is the time to assess your compliance posture
Its research profile is unusually broad for a single compound